NCT01920048

Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure

REVascularisation for Ischaemic VEntricular Dysfunction (REVIVED): a Randomized Comparison of Percutaneous Coronary Intervention (With Optimal Medical Therapy) Versus Optimal Medical Therapy Alone for Treatment of Heart Failure Secondary to Coronary Disease

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 700 (actual)
• Sponsor: King's College London · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will assess whether percutaneous coronary intervention (angioplasty of the heart arteries) can improve survival and reduce hospitalization in patients with heart failure due to coronary disease, who have been treated with the best contemporary medical therapy.

Conditions

• Ischemic Cardiomyopathy

Interventions

Type	Name	Description
PROCEDURE	Percutaneous Coronary Intervention
DRUG	Drug Therapy for Heart Failure	The optimal combination of drugs and doses for each patient will be individualized and will be determined by his/her physician, in accordance with local and international clinical practice guidelines
DEVICE	Device Therapy for Heart Failure	The optimal device therapy for each patient will be individualized and will be determined by his/her physician, in accordance with local and international clinical practice guidelines. In most cases the device will be an Implantable Cardioverter Defibrillator and/or Cardiac Resynchronization Therapy.

Timeline

• Start date: 2013-08-28
• Primary completion: 2020-03-19
• Completion: 2022-03-31
• First posted: 2013-08-09
• Last updated: 2022-05-31

Locations

40 sites across 1 country: United Kingdom